The study found that 24% of MS patients who had recently been exposed to a viral disease such as COVID‐19 or influenza had a greater decrease in FOXP3 expression, which may be due to a significant reduction in the number of Treg cells following chronic neuroinflammation in the setting of viral infection.31 The gene discussed is FOXP3; the disease is myeloid sarcoma.